Experimental model to induce obesity in rats

Acta Cirurgica Brasileira

Volumn 21, Issue 6, 2006, Pages 425-429

  Von Diemen, Vinicius ^a   Trindade, Eduardo Neubarth ^a   Trindade, Manoel Roberto Maciel ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UFRGS ^*  (Brazil)

Author keywords

Metabolism; Models, animal; Obesity; Rats

Indexed keywords

GLUTAMATE SODIUM; FOOD ADDITIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DIETARY INTAKE; EXPERIMENTAL STUDY; FEMALE; GENETIC MANIPULATION; HYPOTHALAMUS LESION; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; NEWBORN; NONHUMAN; OBESITY; OVARIECTOMY; RAT; ANIMAL; BIOLOGICAL MODEL; DISEASE MODEL; DRUG EFFECT; FAT INTAKE; GENETICS; HUMAN; INJURY; REVIEW; WEIGHT GAIN;

ANIMALS; DIETARY FATS; DISEASE MODELS, ANIMAL; FOOD ADDITIVES; HUMANS; MODELS, GENETIC; OBESITY; OVARIECTOMY; RATS; SODIUM GLUTAMATE; VENTROMEDIAL HYPOTHALAMIC NUCLEUS; WEIGHT GAIN;

EID: 33845646378     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/S0102-86502006000600013     Document Type: Article

References (55)

1. Gastrointestinal Surgery for Severe Obesity. NIH Consens Statement. 1991;9(1):1-2.
2. Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH, et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med. 2001;161:1581-6.
3. York DA. Lessons from animal models of obesity. Endocrinol Metab Clin North Am. 1996;25(4):781-800.
4. Mozes S, Sefcikov Z, Lenhardt L, Racek L. Effect of adrenalectomy on the activity of small intestine enzymes in monosodium glutamate obese rats. Physiol Res. 2004;53(4):415-22.
5. Nakagawa T, Ukai K, Ohyama T, Gomita Y, Okamura H. Effects of chronic administration of sibutramine on body weight, food intake and motor activity in neonatally monosodium glutamate-treated obese female rats: relationship of antiobesity effect with monoamines. Exp Anim. 2000;49(4):239-49.
6. Shimizu Y, Yamazaki M, Nakanish K, Sakurai M, Sanada A, Takewaki T, et al. Enhanced responses of the chorda tympani nerve to sugars in the ventromedial hypothalamic obese rat. J Neurophysiol. 2003;90:128-33.
7. Chu SC, Chou YC, Liu JY, Chen CH, Shyu JC, Chou FP. Fluctuation of serum leptin level in rats after ovariectomy and the influence of estrogen supplement. Life Sci. 1999;64(24):2299-306.
8. Xu Y, Ramos EJ, Middleton F, Romanova I, Quinn R, Chen C, et al. Gene expression profiles post Roux-en-Y gastric bypass. Surgery. 2004;136(2):246-52.
9. Prunet-Marcassus B, Desbazeille M, Bros A, Louhce K, Delagrange P, Renard P, et al. Melatonin reduces body weight gain in Sprague Dawlwy rats with diet-induced obesity. Endocrinology. 2003;144:5347-52.
10. Lorden JF, Caudle A. Behavioral and endocrinological effects of single injections of monosodium glutamate in the mouse. Neurobehav Toxicol Teratol. 1986 Sep;8(5):509-19.
11. Guimaraes RB, Telles MM, Coelho VB, Mori RC, Nascimento CM, Ribeiro EB. Adrenalectomy abolishes the food-induced hypothalamic serotonin release in both normal and monosodium glutamate-obese rats. Brain Res Bull. 2002;58(4):363-9.
12. Martins AC, Souza KL, Shio MT, Mathias PC, Lelkes PI, Garcia RM. Adrenal medullary function and expression of catecholamine-synthesizing enzymes in mice with hypothalamic obesity. Life Sci. 2004;74(26):3211-22.
13. Miskowiak B, Partyka M. Effects of neonatal treatment with MSG (monosodium glutamate) on hypothalamo-pituitary-thyroid axis in adult male rats. Histol Histopathol. 1993;8(4):731-4.
14. Lorden JF, Caudle A. Behavioral and endocrinological effects of single injections of monosodium glutamate in the mouse. Neurobehav Toxicol Teratol. 1986;8(5):509-19.
15. Moreno G, Perello M, Camihort G, Luna G, Console G, Gaillard RC, et al. Impact of transient correction of increased adrenocortical activity in hypothalamo-damaged, hyperadipose female rats. Int J Obes. (Lond) 2005 Oct 11.
16. Perello M, Gaillard RC, Chisari A, Spinedi E. Adrenal enucleation in MSG-damaged hyperleptinemic male rats transiently restores adrenal sensitivity to leptin. Neuroendocrinology. 2003;78(3):176-84.
17. Tokuyama K, Himms-Hagen J. Adrenalectomy prevents obesity in glutamate-treated mice. Am J Physiol. 1989;257(2 Pt 1):E139-44.
18. Shivshankar P, Devi SC. Screening of stimulatory effects of dietary risk factors on mouse intestinal cell kinetics. World J Gastroenterol. 2005;11(2):242-8.
19. Bunyan J, Murrell EA, Shah PP. The induction of obesity in rodents by means of monosodium glutamate. Br J Nutr. 1976;35(1):25-39.
20. de Carvalho PP, Vargas AM, da Silva JL, Nunes MT, Machado UF. GLUT4 protein is differently modulated during development of obesity in monosodium glutamate-treated mice. Life Sci. 2002;71(16):1917-28.
21. de Mello MA, de Souza CT, Braga LR, dos Santos JW, Ribeiro IA, Gobatto CA. Glucose tolerance and insulin action in monosodium glutamate (MSG) obese exercise-trained rats. Physiol Chem Phys Med NMR. 2001;33(1):63-71.
22. de Souza CT, Nunes WM, Gobatto CA, de Mello MA. Insulin secretion in monosodium glutamate (MSG) obese rats submitted to aerobic exercise training. Physiol Chem Phys Med NMR. 2003;35(1):43-53.
23. Dolnikoff M, Martin-Hidalgo A, Machado UF, Lima FB, Herrera E. Decreased lipolysis and enhanced glycerol and glucose utilization by adipose tissue prior to development of obesity in monosodium glutamate (MSG) treated-rats. Int J Obes Relat Metab Disord. 2001;25(3):426-33.
24. Kanarek RB, Meyers J, Meade RG, Mayer J. Juvenile-onset obesity and deficits in caloric regulation in MSG-treated rats. Pharmacol Biochem Behav. 1979;10(5):717-21.
25. Moreno G, Perello M, Camihort G, Luna G, Console G, Gaillard RC, et al. Impact of transient correction of increased adrenocortical activity in hypothalamo-damaged, hyperadipose female rats. Int J Obes. (Lond) 2005 Oct 11.
26. Diniz YS, Faine LA, Galhardi CM, Rodrigues HG, Ebaid GX, Burneiko RC, et al. Monosodium glutamate in standard and high-fiber diets: metabolic syndrome and oxidative stress in rats. Nutrition. 2005;21(6):749-55.
27. Dube MG, Xu B, Kalra PS, Sninsky CA, Kalra SP. Disruption in neuropeptide Y and leptin signaling in obese ventromedial hypothalamic-lesioned rats. Brain Res. 1999;816(1):38-46.
28. King BM. Ventromedial hypothalamic obesity: a reexamination of the irritative hypothesis. Neurosci Biobehav Rev. 1991;15(3):341-7.
29. King BM, Daigrepont PM, Michel RE, Zansler CA, Ahmed JI, Walker A, et al. Hypothalamic obesity: comparison of radio-frequency and electrolytic lesions in weanling rats. Physiol Behav. 1989;45(1):127-32.
30. King BM, Frohman LA. Hypothalamic obesity: comparison of radio-frequency and electrolytic lesions in male and female rats. Brain Res Bull. 1986;17(3):409-13.
31. King BM, Frohman LA. Nonirritative lesions of VMH: effects on plasma insulin, obesity, and hyperreactivity. Am J Physiol. 1985;248(6 Pt 1):E669-75.
32. Dube MG, Xu B, Kalra PS, Sninsky CA, Kalra SP. Disruption in neuropeptide Y and leptin signaling in obese ventromedial hypothalamic-lesioned rats. Brain Res. 1999;816(1):38-46.
33. Scallet AC, Olney JW. Components of hypothalamic obesity: bipiperidyl-mustard lesions add hyperphagia to monosodium glutamate-induced hyperinsulinemia. Brain Res. 1986;374(2):380-4.
34. Dube MG, Xu B, Kalra PS, Sninsky CA, Kalra SP. Disruption in neuropeptide Y and leptin signaling in obese ventromedial hypothalamic-lesioned rats. Brain Res. 1999;816(1):38-46.
35. Chu SC, Chou YC, Liu JY, Chen CH, Shyu JC, Chou FP. Fluctuation of serum leptin level in rats after ovariectomy and the influence of estrogen supplement. Life Sci. 1999;64(24):2299-306.
36. Shimizu H, Shimomura Y, Nakanishi Y, Futawatari T, Ohtani K, Sato N, et al. Estrogen increases in vivo leptin production in rats and human subjects. J Endocrinol. 1997;154(2):285-92.
37. Chen Y, Heiman ML. Increased weight gain after ovariectomy is not a consequence of leptin resistance. Am J Physiol Endocrinol Metab. 2001;280(2):E315-22.
38. Ainslie DA, Morris MJ, Wittert G, Turnbull H, Proietto J, Thorburn AW. Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y. Int J Obes Relat Metab Disord. 2001;25(11):1680-8.
39. Kimura M, Irahara M, Yasui T, Saito S, Tezuka M, Yamano S, et al. The obesity in bilateral ovariectomized rats is related to a decrease in the expression of leptin receptors in the brain. Biochem Biophys Res Commun. 2002;290(4):1349-53.
40. Meli R, Pacilio M, Raso GM, Esposito E, Coppola A, Nasti A, et al. Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats. Endocrinology. 2004;145(7):3115-21.
41. Kamei Y, Suzuki M, Miyazaki H, Tsuboyama-Kasaoka N, Wu J, Ishimi Y, et al. Ovariectomy in mice decreases lipid metabolism-related gene expression in adipose tissue and skeletal muscle with increased body fat. J Nutr Sci Vitaminol. (Tokyo) 2005;51(2):110-7.
42. Pelleymounter MA, Baker MB, McCaleb M. Does estradiol mediate leptin's effects on adiposity and body weight? Am J Physiol. 1999;276(5 Pt 1):E955-63.
43. Shimomura K, Shimizu H, Tsuchiya T, Abe Y, Uehara Y, Mori M. Is leptin a key factor which develops obesity by ovariectomy? Endocrinol J. 2002;49(4):417-23.
44. Shimizu H, Ohtani K, Kato Y, Tanaka Y, Mori M. Withdrawal of [corrected] estrogen increases hypothalamic neuropeptide Y (NPY) mRNA expression in ovariectomized obese rat. Neurosci Lett. 1996;204(1-2):81-4.
45. Henry BA, Goding JW, Alexander WS, Tilbrook AJ, Canny BJ, Dunshea F, et al. Central administration of leptin to ovariectomized ewes inhibits food intake without affecting the secretion of hormones from the pituitary gland: evidence for a dissociation of effects on appetite and neuroendocrine function. Endocrinology. 1999;140(3):1175-82.
46. Ainslie DA, Morris MJ, Wittert G, Turnbull H, Proietto J, Thorburn AW. Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y. Int J Obes Relat Metab Disord. 2001;25(11):1680-8.
47. Naderali EK, Fatani S, Wiliams G. Chronic withdrawal of a high-palatable obesity-inducing diet completely reverses metabolic and vascular abnormalities associated with dietary-obesity in the rat. Atherosclerosis. 2004;172:63-9.
48. Meguid MM, Ramos EFB, Suzuki S, Xu Y, George ZM, Hughes K, et al. A Surgical rat model of human Roux-en-y gastric bypass. J Gastrointest Surg. 2004;8:621-30.
49. Marques-Lopes I, Marti A, Moreno-Aliaga MJ, Martinez A. Aspectos geneticos da obesidade. Rev Nutr. 2004;17(3):327-38.
50. Chagnon Y C, Bouchard C. Genetics of obesity: advances from rodents studies. TGI. 1996;12(11).
51. Good D.J. Using obese mouse models in research: special considerations for IACUC members, animal care technicians, and researchers. Lab Animal. 2005;34(2):30-7.
52. Carroll L, Voisey J, Van Daall A. Mouse models of obesity. Clin Dermatol. 2004;22:345-9.
53. Mynatt RL, Miltenberger RJ, Klebig ML, et al. Combined effects of insulin treatment and adipose tissue-specific agouti expression on the development of obesity. Natl Acad Sci USA. 1997;94:919-22.
54. Brockmann GA, Bevova MR. Using mouse models to dissect the genetics of obesity. Trends Genet. 2002;18(7):367-76.
55. Robinson SW, Dinulesco DM, Cone RD. Genetic models of obesity and energy balance in the mouse. Ann Rev Genet. 2000;34:687-745.